Lifecare (LIFE) Stock Overview
Operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
LIFE Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
Lifecare ASA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NOK 5.52 |
52 Week High | NOK 25.22 |
52 Week Low | NOK 5.24 |
Beta | -0.77 |
1 Month Change | -13.75% |
3 Month Change | -40.65% |
1 Year Change | -77.07% |
3 Year Change | -90.52% |
5 Year Change | -92.42% |
Change since IPO | -79.59% |
Recent News & Updates
Recent updates
TTP Collaboration And Sensor Chemistry Will Streamline Manufacturing
Strategic partnerships and technological advancements could significantly enhance market position and revenue growth through improved product efficiency and expanded market access.We Think Lifecare (OB:LIFE) Can Afford To Drive Business Growth
Sep 13We're Interested To See How Lifecare (OB:LIFE) Uses Its Cash Hoard To Grow
Apr 30Shareholder Returns
LIFE | NO Medical Equipment | NO Market | |
---|---|---|---|
7D | -0.7% | 1.5% | 0.6% |
1Y | -77.1% | -0.9% | 7.6% |
Return vs Industry: LIFE underperformed the Norwegian Medical Equipment industry which returned -2.5% over the past year.
Return vs Market: LIFE underperformed the Norwegian Market which returned 8.6% over the past year.
Price Volatility
LIFE volatility | |
---|---|
LIFE Average Weekly Movement | 10.6% |
Medical Equipment Industry Average Movement | 6.0% |
Market Average Movement | 5.3% |
10% most volatile stocks in NO Market | 13.6% |
10% least volatile stocks in NO Market | 3.1% |
Stable Share Price: LIFE's share price has been volatile over the past 3 months compared to the Norwegian market.
Volatility Over Time: LIFE's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Norwegian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 32 | Joacim Holter | lifecare.no |
Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures pressure, temperature, force, or various other performance indicators in live tissue; and medical devices that remove subdermal implants.
Lifecare ASA Fundamentals Summary
LIFE fundamental statistics | |
---|---|
Market cap | NOK 105.21m |
Earnings (TTM) | -NOK 78.98m |
Revenue (TTM) | NOK 9.26m |
Is LIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LIFE income statement (TTM) | |
---|---|
Revenue | NOK 9.26m |
Cost of Revenue | NOK 0 |
Gross Profit | NOK 9.26m |
Other Expenses | NOK 88.24m |
Earnings | -NOK 78.98m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 20, 2025
Earnings per share (EPS) | -4.14 |
Gross Margin | 100.00% |
Net Profit Margin | -852.52% |
Debt/Equity Ratio | 0% |
How did LIFE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/07/09 05:11 |
End of Day Share Price | 2025/07/09 00:00 |
Earnings | 2025/03/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Lifecare ASA is covered by 1 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Ludvig Svensson | DNB Carnegie Commissioned Research |